SVCM
ZURA icon

Saturn V Capital Management’s Zura Bio ZURA Stock Holding History

Saturn V Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.4M Buy
+739,960
New +$4.47M 0.8% 19

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Saturn V Capital Management's ZURA Position: Q1 2026 in Review

Saturn V Capital Management opened a new position in Zura Bio (ZURA) in Q1 2026: 739,960 shares worth $4.4M. The stake represents 0.8% of the portfolio and ranks #19 among its holdings.

94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Saturn V Capital Management held 739,960 shares of Zura Bio worth $4.4M as of Q1 2026.
  • Zura Bio was a new Saturn V Capital Management position in Q1 2026.
  • Zura Bio made up 0.8% of Saturn V Capital Management's portfolio in Q1 2026, its #19 holding.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Saturn V Capital Management's 13F filing for Q1 2026, filed 15 May 2026.